首页GRAL • NASDAQ
add
Grail Inc
昨日收盘价
$43.06
当日价格范围
$44.31 - $46.32
年度波幅
$20.44 - $118.84
市值
18.79亿 USD
平均交易量
175.92万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
收入 | 4359.70万 | 13.97% |
经营支出 | 1.47亿 | 28.76% |
净收入 | -9917.60万 | -2.17% |
净利润率 | -227.48 | 10.35% |
每股收益 | -2.44 | — |
息税折旧摊销前利润 | -8550.30万 | -49.94% |
有效税率 | 14.88% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 9.04亿 | 18.46% |
总资产 | 29.22亿 | -2.05% |
负债总额 | 3.44亿 | -28.29% |
权益总额 | 25.78亿 | — |
发行在外的股份 | 4102.03万 | — |
市净率 | 0.67 | — |
资产回报率 | -11.26% | — |
资本回报率 | -12.61% | — |
现金流
现金净变动
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
净收入 | -9917.60万 | -2.17% |
来自运营的现金 | -6378.50万 | 31.77% |
投资现金 | -2.37亿 | 56.66% |
融资现金 | 4.23亿 | — |
现金净变动 | 1.23亿 | 119.20% |
自由现金流 | -2080.19万 | -171.95% |
简介
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
成立时间
2015
员工数量
910
